Immutep

SYDNEY, Australia – July 24, 2026 Immutep Limited has announced that an abstract from its investigator-initiated Phase II EFTISARC-NEO...

SYDNEY, Australia, July 13, 2026 Immutep announced positive mature overall survival data from its investigator-initiated Phase 1 INSIGHT-003 trial...

Sydney, Australia | April 15, 2026 Immutep Limited has achieved a significant regulatory milestone with the U.S. Food and...